Skip to main content
Clinical Trials/NCT07132216
NCT07132216CompletedNot Applicable

Effect of Virtual Reality on Intraoperative Anxiety, Stress and Patient's Satisfaction Among Palestinian Patients Undergoing Regional Anesthesia

Cairo University1 site in 1 country150 target enrollmentStarted: July 17, 2024Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
150
Locations
1
Primary Endpoint
The State-Trait Anxiety Inventory (STAI)

Study Overview

Brief Summary

The goal of this clinical trial was to investigate the effect of Virtual Reality (VR) on intraoperative anxiety, stress, and patient satisfaction among Palestinian patients undergoing regional anesthesia. The study aimed to determine the efficacy and safety of VR as a non-pharmacological intervention during surgery. The main research hypotheses are:

H0: There will be no significant difference in anxiety levels between patients who receive immersive VR during regional anesthesia and those who do not receive pre- and post-virtual reality therapy.

H0: There will be no significant difference in perceived stress levels between patients who receive immersive VR during regional anesthesia and those who do not receive pre- and post-virtual reality therapy.

H0: There will be no significant difference in satisfaction levels between patients who receive immersive VR during regional anesthesia and those who do not receive pre- and post-virtual reality therapy.

Participants will:

Receive either VR intervention or standard care during their surgery. Complete assessments of anxiety and stress before and after the procedure using validated scales.

Provide feedback on their satisfaction levels post-operation using a Visual Analog Scale.

Be monitored for hemodynamic parameters throughout the surgical process.

Detailed Description

Title: Effect of Virtual Reality on Intraoperative Anxiety, Stress, and Patient Satisfaction among Palestinian Patients Undergoing Regional Anesthesia

Background: Preoperative and intraoperative anxiety and stress are common psychological responses that negatively impact surgical outcomes and patient satisfaction. While pharmacological interventions are traditionally used to manage these responses, non-pharmacological methods such as virtual reality (VR) are gaining prominence. This study aimed to evaluate the effect of VR on intraoperative anxiety, stress, and patient satisfaction among Palestinian patients undergoing regional anesthesia.

Methods: A randomized controlled trial was conducted at Rafidia Governmental Surgical Hospital in Nablus, Palestine, from June to September 2024. A total of 150 patients scheduled for elective urological surgery under regional anesthesia were randomly assigned into VR (n=75) and control (n=75) groups. Participants in the VR group received immersive VR intervention during the operation using head-mounted devices, while the control group received routine care. Anxiety was assessed using the State-Trait Anxiety Inventory (STAI), stress using the Perceived Stress Scale (PSS-10), and patient satisfaction using the Visual Analog Scale (VAS). Hemodynamic parameters were also monitored.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Supportive Care
Masking
None

Masking Description

Patients were not blinded due to the VR intervention, but the anesthesiologist and outcome assessors were blinded to group assignments. To maintain blinding for the anesthesiologist, VR headsets were covered with opaque drapes during clinical assessments, and research staff members not involved in clinical care managed the VR equipment. The anesthesiologist was only informed of group allocation after completing all clinical assessments.

Eligibility Criteria

Ages
18 Years to 70 Years (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Patients who underwent elective urological surgery under regional anesthesia
  • •Patients older than 18 years
  • •Patients with no history of previous surgeries
  • •Patients suffering from moderate to severe anxiety and stress

Exclusion Criteria

  • •Patients with a history of psychiatric disorders, epilepsy, hypertension, or chronic pain
  • •Patients who are mute and cannot read or write; patients with visual, hearing, or cognitive impairment
  • •Patients with implanted hearing aids or cardiac pacemakers
  • •Patients who received any anxiolytic, sedative, or hypnotic drugs before or during regional anesthesia
  • •Patients exposed to anesthetic or surgical complications during the operation

Arms & Interventions

VR group

Experimental

The Meta Quest 2 VR headset with built-in headphones was used. Patients selected VR environments from a predefined list of five nature scenes (beach, forest, mountain, underwater, and meadow) with identical meditation audio tracks lasting 30 minutes each. Guided Meditation VR from Cubicle Ninjas (https://guidedmeditationvr.com/)featured 360-degree nature environments with standardized calming background music and guided meditation narration. VR was applied immediately after spinal anesthesia and before the surgical incision. Sessions lasted 30 minutes and were discontinued if the patient reported nausea, dizziness, or requested removal.

Intervention: Meta Quest 2 VR headset (Device)

control group

No Intervention

Participants in the control group only receive standard care according to the hospital's protocol during the operation.

Outcomes

Primary Outcomes

The State-Trait Anxiety Inventory (STAI)

Time Frame: preoperative and then 60 minutes postoperatively

The STAI score ranges between 20-80, the higher score indicating greater anxiety. It is classified as "no or low anxiety" (20-37), "moderate anxiety" (38-44), and "high anxiety" (45-80).

Perceived Stress Scale (PSS-10)

Time Frame: preoperative and 60 minutes postoperatively

The PSS-10 score can range from 0 to 40 with higher scores indicating higher perceived stress. It is classified as "no or low anxiety" (0-13), "moderate anxiety" (14-26), and "high anxiety" (27-40).

Secondary Outcomes

No secondary outcomes reported

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

khulud "Mohammad Hasham" Hasham Mansor

Principal Investigator

Cairo University

Study Sites (1)

Loading locations...

Similar Trials